Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 55 resultados

MALDIBANK: Multi domain Open MALDI Spectra Archive for Identification of Microorganisms MALDIBANK: A Comprehensive Solution to Microbial Challenges In an era marked by pressing environmental and health challenges, including cli...
2024-10-23 - 2029-04-30 | Financiado

EPACE: European compact accelerators their applications and entrepreneurship BRITEST LBG participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 New technologies of compact accelerators, in particular plasma accelerators, and laser-based x-ray sources, are on the verge of reaching mat...
2024-07-03 - 2028-12-31 | Financiado

EU-LAC ResInfra Plus: TOWARDS A SUSTAINABLE EU LAC PARTNERSHIP IN RESEARCH INFRASTRUCTURES BRITEST LBG participó en un HORIZON EUROPE: HORIZON-INFRA-2023-DEV-01 H2020 EU-LAC ResInfra project served to boost the bi-regional collaboration on research infrastructures (RIs) between European Union (EU) an...
2023-11-03 - 2025-12-31 | Financiado

EOSC Beyond: EOSC Beyond advancing innovation and collaboration for research BRITEST LBG participó en un HORIZON EUROPE: HORIZON-INFRA-2023-EOSC-01 EOSC Beyond overall objective is to advance Open Science and innovation in research in the context of the European Open Science Cloud (EOSC)...
2023-10-27 - 2027-03-31 | Financiado

GREEN-LOG: Cooperative and Interconnected Green delivery solutions towards an era of optimized zero emission la... BRITEST LBG participó en un HORIZON EUROPE: HORIZON-CL5-2021-D6-01 GreenLog accelerates systemic changes in last mile delivery ecosystems for economically, environmentally and socially sustainable city logis...
2022-12-16 - 2026-06-30 | Financiado

Fragment-Screen: From fragments to high affinity binders interfacing integrated structural biology medicinal chemist... BRITEST LBG tramitó un HORIZON EUROPE: HORIZON-INFRA-2022-TECH-01 Fragment-Screen will develop innovative instrumentation, workflows and experimental and computational methodologies for fragment-based drug...
2022-12-13 - 2026-01-31 | Financiado

EOSC4Cancer: A European wide foundation to accelerate Data driven Cancer Research BRITEST LBG participó en un HORIZON EUROPE: HORIZON-INFRA-2021-EOSC-01 Cancer complex nature requires integration of advanced research data across national boundaries to enable progress. Indeed, the Horizon Euro...
2022-06-09 - 2025-02-28 | Financiado

AI4LIFE: Artificial Intelligence for Image Data Analysis in the Life Sciences BRITEST LBG participó en un HORIZON EUROPE: HORIZON-INFRA-2021-SERV-01 Machine learning (ML) has enabled and accelerated frontier research in the life sciences, but democratised access to such methods is, unfort...
2022-05-31 - 2025-08-31 | Financiado

ETERNAL: Boosting the reduction of the environmental impact of pharmaceutical products throughout their entir... BRITEST LBG participó en un HORIZON EUROPE: HORIZON-HLTH-2021-IND-07 ETERNAL aims to contribute to sustainable development of pharmaceutical manufacture, use and disposal, by using and promoting full life cycl...
2022-05-23 - 2026-08-31 | Financiado

eRImote: European Research Infrastructures - Pathway to Improved Resilience and Digital and Remote Access BRITEST LBG participó en un HORIZON EUROPE: HORIZON-INFRA-2021-DEV-01 The eRImote project is the first to consider solutions for digital and remote service provision across RI domains and to look for transferab...
2022-05-02 - 2024-11-30 | Financiado

BY-COVID: Beyond COVID BRITEST LBG participó en un HORIZON EUROPE: HORIZON-INFRA-2021-EMERGENCY-01 Beyond-COVID (BY-COVID) aims to provide comprehensive open data on SARS-CoV-2, and other infectious diseases across scientific, medical, pub...
2022-02-23 - 2024-09-30 | Financiado

ISIDORe: Integrated Services for Infectious Disease Outbreak Research BRITEST LBG participó en un HORIZON EUROPE: HORIZON-INFRA-2021-EMERGENCY-02 The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest...
2022-02-09 - 2025-07-31 | Financiado

EOSC Future: EOSC Future BRITEST LBG participó en un H2020: H2020-INFRAEOSC-2018-2020 EOSC Future responds to INFRAEOSC-03-2020 call in order to integrate, consolidate, and connect e-infrastructures, research communities, and...
2021-07-05 - 2024-03-31 | Financiado

PRISM 2: Psychiatric Ratings using Intermediate Stratified Markers 2 BRITEST LBG participó en un H2020: H2020-JTI-IMI2-2020-22-single-stage The current nosology of neuropsychiatric disorders provides a pragmatic approach to diagnosis and treatment choice but lacks reference to qu...
2021-05-19 - 2024-11-30 | Financiado

FRONTIER: Next generation traffic management for empowering CAVs integration cross stakeholders collaboration... BRITEST LBG participó en un H2020: H2020-MG-2018-2019-2020 FRONTIER aims to provide the network and integrated traffic management strategies of the future, taking into account new types and modes of...
2021-03-26 - 2024-04-30 | Financiado

BioBased ValueCircle: Training the new generation of industrial doctorates in the transition towards bio based value circl... BRITEST LBG participó en un H2020: H2020-MSCA-ITN-2020 BioBased ValueCircle offers a unique interdisciplinary research and training environment tailored for early stage researchers (ESRs) excited...
2020-09-04 - 2024-08-31 | Financiado

TRANSVAC-DS: DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE BRITEST LBG participó en un H2020: H2020-SC5-2018-2019-2020 The TRANSVAC-DS project further builds on the outstanding success of EC-funded projects:TRANSVAC1 and TRANSVAC2 and proposes the establishme...
2020-06-09 - 2023-02-28 | Financiado

iNEXT-Discovery: Infrastructure for transnational access and discovery in structural biology BRITEST LBG participó en un H2020: H2020-INFRAIA-2018-2020 Structural biology reveals the molecular architecture of life; the three-dimensional structure of biomolecules and how they interact to form...
2019-12-16 - 2024-07-31 | Financiado

EU-PEARL: EU Patient cEntric clinicAl tRial pLatform BRITEST LBG participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage EU-PEARL has the ambition of transforming the current approach of conducting single-compound clinical trials into the use of cross-company I...
2019-11-27 - 2023-04-30 | Financiado